Theravance Biopharma, Inc. (TBPH) SEC Filings — 2024
28 SEC filings for Theravance Biopharma, Inc. (TBPH) in 2024.
Filings
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Theravance Biopharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Theravance Biopharma Files 8-K on Operations and Financials — 8-K · Nov 12, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Oct 24, 2024
- Royalty Pharma to Acquire Theravance Biopharma for $1/Share — 8-K · Sep 23, 2024
- Theravance Biopharma, Inc. 8-K Filing — 8-K · Sep 10, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Sep 9, 2024
- Theravance Biopharma, Inc. SC 13G Filing — SC 13G · Aug 16, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Aug 9, 2024
- Theravance Biopharma Q2 Revenue Down, Net Loss Persists — 10-Q · Aug 8, 2024
- Theravance Biopharma Files 8-K on Financials — 8-K · Aug 5, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Jun 11, 2024
- Theravance Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Theravance Biopharma Files 8-K on Financials — 8-K · May 13, 2024
- Theravance Biopharma Files 8-K on Shareholder Vote Matters — 8-K · May 9, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · May 3, 2024
- Theravance Biopharma, Inc. Announces 2024 Annual General Meeting Details — DEF 14A · Apr 5, 2024
- Weiss Asset Management amends Theravance Biopharma stake — SC 13D/A · Mar 5, 2024
- Theravance Biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 1, 2024
- Theravance Biopharma Files 8-K for 'Other Events' — 8-K · Feb 28, 2024
- Theravance Biopharma Files 8-K on Financial Condition — 8-K · Feb 26, 2024
- Theravance Biopharma, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Theravance Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends Theravance Biopharma Stake as of Dec 31, 2023 — SC 13G/A · Feb 8, 2024
- Theravance Biopharma 8-K Confirms NASDAQ Listing, No New Material Events — 8-K · Jan 16, 2024
- TBPH Files 8-K for 'Other Events' and Financial Exhibits — 8-K · Jan 5, 2024